{"Title": "Glycogen synthase kinase-3\u03b2 regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer\u2019s disease", "Year": 2017, "Source": "Cell. Mol. Life Sci.", "Volume": "74", "Issue": 6, "Art.No": null, "PageStart": 1153, "PageEnd": 1163, "CitedBy": 6, "DOI": "10.1007/s00018-016-2408-6", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84994727922&origin=inward", "Abstract": "\u00a9 2016, The Author(s).Glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) is a serine-threonine kinase implicated in multiple processes and signaling pathways. Its dysregulation is associated with different pathological conditions including Alzheimer\u2019s disease (AD). Here we demonstrate how changes in GSK-3\u03b2 activity and/or levels regulate the production and subsequent secretion of fractalkine, a chemokine involved in the immune response that has been linked to AD and to other different neurological disorders. Treatment of primary cultured neurons with GSK-3\u03b2 inhibitors such as lithium and AR-A014418 decreased full-length fractalkine in total cell extracts. Opposite effects were observed after neuron transduction with a lentiviral vector overexpressing the kinase. Biotinylation assays showed that those changes mainly affect the plasma membrane-associated form of the protein, an observation that positively correlates with changes in the levels of its soluble form. These effects were confirmed in lithium-treated wild type (wt) mice and in GSK-3\u03b2 transgenic animals, as well as in brain samples from AD patients, evident as age-dependent (animals) or Braak stage dependent changes (humans) in both the membrane-bound and the soluble forms of the protein. Further immunohistochemical analyses demonstrated how GSK-3\u03b2 exerts these effects by affecting the trafficking of the chemokine from the Golgi to the plasma membrane, in different and opposite ways when the levels/activity of the kinase are increased or decreased. This work provides for the first time a mechanism linking GSK-3\u03b2 and fractalkine both in vitro and in vivo, with important implications for neurological disorders and especially for AD, in which levels of this chemokine might be useful as a diagnostic tool.", "AuthorKeywords": ["Alzheimer\u2019s disease", "Fractalkine", "Golgi network", "GSK-3\u03b2", "Rab8"], "IndexKeywords": ["Alzheimer Disease", "Animals", "Cell Membrane", "Chemokine CX3CL1", "Glycogen Synthase Kinase 3 beta", "Golgi Apparatus", "Humans", "Mice, Inbred C57BL", "Protein Binding", "Protein Transport", "rab GTP-Binding Proteins", "Solubility", "Transport Vesicles"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84994727922", "SubjectAreas": [["Molecular Medicine", "BIOC", "1313"], ["Molecular Biology", "BIOC", "1312"], ["Pharmacology", "PHAR", "3004"], ["Cellular and Molecular Neuroscience", "NEUR", "2804"], ["Cell Biology", "BIOC", "1307"]], "AuthorData": {"26642338400": {"Name": "Fuster-Matanzo A.", "AuthorID": "26642338400", "AffiliationID": "60085102, 60001602", "AffiliationName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)"}, "55195957400": {"Name": "Jurado-Arjona J.", "AuthorID": "55195957400", "AffiliationID": "60085102, 60001602", "AffiliationName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)"}, "26967494900": {"Name": "Benvegn\u00f9 S.", "AuthorID": "26967494900", "AffiliationID": "60018505", "AffiliationName": "Department of Molecular Neurobiology, Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM)"}, "57220844655": {"Name": "Garc\u00eda E.", "AuthorID": "57220844655", "AffiliationID": "60018505", "AffiliationName": "Department of Molecular Neurobiology, Centro de Biolog\u00eda Molecular Severo Ochoa (CSIC-UAM)"}, "35368787100": {"Name": "Mart\u00edn-Maestro P.", "AuthorID": "35368787100", "AffiliationID": "60085102, 60001602", "AffiliationName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)"}, "7202801197": {"Name": "Hern\u00e1ndez F.", "AuthorID": "7202801197", "AffiliationID": "60085102, 60001602", "AffiliationName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)"}, "36047921700": {"Name": "\u00c1vila J.", "AuthorID": "36047921700", "AffiliationID": "60085102, 60001602", "AffiliationName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)"}, "16444023600": {"Name": "G\u00f3mez-Sintes R.", "AuthorID": "16444023600", "AffiliationID": "60009305, 60006754", "AffiliationName": "Departament of Cellular and Molecular Biology, Centro de Investigaciones Biol\u00f3gicas, CSIC"}}}